Oral Delivery of Tocotrienols: Addressing Pharmacokinetic Challenges With Formulation-Based Strategies

Area of Science:

• Pharmacology and Drug Delivery
• Nutritional Science
• Biochemistry

Background:

• Tocotrienols (T3), vitamin E analogues, possess significant antioxidant and therapeutic potential.
• Clinical applications of T3 are limited by poor and inconsistent oral bioavailability.
• Factors contributing to low bioavailability include poor solubility, rapid elimination, instability, and limited protein binding.

Purpose of the Study:

• To review the pharmacokinetics of tocotrienols.
• To critically evaluate advanced oral delivery systems for improving T3 bioavailability.
• To identify future strategies for overcoming T3 absorption barriers.

Main Methods:

• Literature review of pharmacokinetic studies on T3.
• Analysis of recent developments in T3 oral delivery systems.
• Examination of intestinal absorption mechanisms, including transporter involvement (NPC1L1, SR-B1).

Main Results:

• T3 absorption is a saturable, concentration-dependent process mediated by specific intestinal transporters.
• Current delivery systems show some improvement in bioavailability but do not fully resolve intrinsic absorption limitations.
• Challenges include rapid elimination, low solubility, and chemical instability.

Conclusions:

• Overcoming T3 bioavailability issues requires integrated physicochemical and biological approaches.
• Modulating intestinal transporters and controlling drug release kinetics are crucial for consistent absorption.
• Next-generation T3 formulations aim for prolonged circulation and enhanced therapeutic outcomes.